• No results found

Clinical pharmacology of cannabinoids in early phase drug development Zuurman, H.H.

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "Clinical pharmacology of cannabinoids in early phase drug development Zuurman, H.H."

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 7 pagina )

Hele tekst

(1)

Clinical pharmacology of cannabinoids in early phase drug development

Zuurman, H.H.

Citation

Zuurman, H. H. (2008, May 28). Clinical pharmacology of cannabinoids in early phase drug development. Retrieved from

https://hdl.handle.net/1887/12869

Version: Corrected Publisher’s Version License:

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12869

Note: To cite this publication please use the final published version (if

applicable).

(2)

DMJOJDBMQIBSNBDPMPHZPGDBOOBCJOPJETJOFBSMZQIBTFESVHEFWFMPQNFOU

(3)
(4)

$MJOJDBMQIBSNBDPMPHZ

PGDBOOBCJOPJETJOFBSMZ

QIBTFESVHEFWFMPQNFOU

QSPFGTDISJGU

UFSWFSLSJKHJOHWBOEFHSBBEWBO%PDUPSBBOEF6OJWFSTJUFJU-FJEFO 

PQHF[BHWBO3FDUPS.BHOJ¾DVTQSPGNS1'WBOEFS)FJKEFO 

WPMHFOTCFTMVJUWBOIFU$PMMFHFWPPS1SPNPUJFTUFWFSEFEJHFOPQ

XPFOTEBHNFJLMPLLFVVS

EPPS)JMMJF)FOLB;VVSNBO HFCPSFOUF)PPHF[BOE4BQQFNFFSJO

(5)

QSPNPUJFDPNNJTTJF

 1SPNPUPSFT 1SPG%S"'$PIFO 1SPG%S+."WBO(FSWFO

 3FGFSFOU 1SPG%S$(,SVTF

 0WFSJHFMFEFO 1SPG%S.%BOIPG

1SPG%S&3EF,MPFU

1SPG%S37FSQPPSUF

 %FTJHO

$BSPMJOFEF-JOU 7PPSCVSH DBSP!EFMJOUOM

5IFQSJOUJOHPGUIJTUIFTJTXBT¾OBODJBMMZTVQQPSUFECZUIFGPVOEBUJPO

´$FOUSFGPS)VNBO%SVHSFTFBSDIµ -FJEFO 5IF/FUIFSMBOET



(6)

  

 JOUSPEVDUJPO

  

 CJPNBSLFSTGPSUIFFGGFDUTPGDBOOBCJTBOEUIDJOIFBMUIZ

WPMVOUFFST

  

 FGGFDUPGJOUSBQVMNPOBSZUIDBENJOJTUSBUJPOJOIVNBOT

  

 NPEFMMJOHPGUIFDPODFOUSBUJPOFGGFDUSFMBUJPOTIJQPG

UIDPODFOUSBMOFSWPVTTZTUFNQBSBNFUFSTBOEIFBSUSBUF°

JOTJHIUJOUPJUTNFDIBOJTNTPGBDUJPOBOEBUPPMGPSDMJOJDBM

SFTFBSDIBOEEFWFMPQNFOUPGDBOOBCJOPJET

  

 FWBMVBUJPOPGUIDJOEVDFEUBDIZDBSEJBJOIVNBOTVTJOH

IFBSUSBUFWBSJBCJMJUZ

  

 JOIJCJUJPOPGUIDJOEVDFEFGGFDUTPOUIFDFOUSBMOFSWPVT

TZTUFNBOEIFBSUSBUFCZBOPWFMDCSFDFQUPSBOUBHPOJTU

BWF

  

 QIBSNBDPEZOBNJDBOEQIBSNBDPLJOFUJDFGGFDUTPGUIF

JOUSBWFOPVTMZBENJOJTUFSFEDCSFDFQUPSBHPOJTUPSH

JOIFBMUIZNBMFWPMVOUFFST

  

 QIBSNBDPEZOBNJDBOEQIBSNBDPLJOFUJDFGGFDUTPGUIF

JOUSBWFOPVTDCSFDFQUPSBHPOJTUPSHJOIFBMUIZ

NBMFWPMVOUFFST

  

 TVNNBSZBOEDPODMVTJPOT

  

 OFEFSMBOETFJOMFJEJOH TBNFOWBUUJOHFODPODMVTJFT

 DVSSJDVMVNWJUBF























(7)

Referenties

Download het nu ( PDF - 7 pagina - 674.03 KB )

GERELATEERDE DOCUMENTEN

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Since expression of Serpins may facilitate the immune escape of HLA positive tumors, we next analysed the effect of Serpin expression on survival in cases with normal/partial

Clinical pharmacology of cannabinoids in early phase drug development Zuurman, H.H.

TVCKFDUT 5XFOUZPOFNBMFIFBMUIZWPMVOUFFSTXFSFTDSFFOFEBOEGPVOEUPCFIFBMUIZ EFUFSNJOFE GSPN NFEJDBM IJTUPSZ QIZTJDBM FYBNJOBUJPO MBCPSBUPSZ BOE VSJOF TDSFFOT BOE FMFDUSPDBSEJPHSBQIZ

Clinical pharmacology of cannabinoids in early phase drug development Zuurman, H.H.

TVCKFDUT0OMZUIFTMPXJOGVTJPOPG0SHQSPEVDFEQTZDIPMPHJDBMBE WFSTFFGGFDUT TPUIJTXBTVOSFMBUFEUPBSBQJEJODSFBTFJOQMBTNB PSCSBJO

Clinical pharmacology of cannabinoids in early phase drug development Zuurman, H.H.

UJWFNFBTVSFPGTFEBUJPOGPSCFO[PEJB[FQJOFT 5IFTFUXPDPNQPVOET BSFUIFSFGPSFOPUTVJUBCMFGPSQSPWJEJOHTFEBUJPOGPSEBZDBSFTVSHJDBMQSP DFEVSFT " XFMMLOPXO DIBSBDUFSJTUJD PG NJEB[PMBN

Clinical pharmacology of cannabinoids in early phase drug development Zuurman, H.H.

5 For the development of cannabinoids in general it is worthwhile to unravel the complex cardiovascular mechanisms in humans since cardiovascular side effects

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

This shape also occurs in the combination artefacts (see below). The shape is the result of intensive use in a repetitive abrasive motion, carried out from different angles. In